The CureMatch report ranks the top 2-, 3-, and 4-drug combination therapy options available for a patient. Standard chemotherapy, targeted therapy, and immunotherapy treatments are also considered and ranked. If desired, specific treatments recommended by the oncologist can also be scored relative to the options that are provided in the CureMatch report.
The report is not a substitute for the physician’s decision, but rather it permits the physician to make the most informed decision, using the most advanced personalized treatment options. The simple report layout and ranking is designed to provide actionable knowledge and insight to the oncologist.
The CureMatch platform takes into consideration activities and toxicities of drugs, and then uses a proprietary rules-based system to rank millions of combinations of drugs and gene aberrations. Priority is given to combinations of drugs covering the highest number of targets, and to combinations using a minimal number of drugs. These criteria are embedded in CureMatch’s Matching Score algorithm calculation, and included on the CureMatch Report.